Check out your Company Bowl for anonymous work chats.
Want to learn more about how Omada members are maintaining their weight loss results after stopping GLP-1s? Read the full 12-month discontinuation report now: https://lnkd.in/em-dwb-p
🚨New Research from Omada Health challenges assumptions about GLP-1 discontinuation 🚨 In a newly published analysis, members in our GLP-1 Care Track maintained their weight loss with just 0.8% average weight change one year after stopping GLP-1 medications. That's compared to 11-12% weight gain typically seen in clinical trials. A key difference? Companion behavior change support. Learn more in our press release: https://lnkd.in/e2ZnNWfg
Think you know the GLP-1 landscape? Here’s one stat about persistence that might surprise you: in one study, a third of people stopped taking their GLP-1 for weight management in the first month. Why? Real-world challenges like access, cost, side effects, and issues around self-administered injections. In Omada’s Enhanced GLP-1 Care Track, it’s a different story. 94% of members were persistent on their medication at 3 months, while 84% were persistent through 6 months. How did members who stayed on their medication fare with weight loss and program engagement? Read our full report to find out. Read it now: https://lnkd.in/eSbhZbFq
Don't miss Sarah Linke, PhD, MPH at the upcoming hashtag#HDPalooza conference next week speaking about how to bridge gaps in virtual health and standardizing value through unified evaluation. We'll also have our Chief Privacy and Regulatory Officer Lucia Savage moderating a panel on evaluating and governing digital and AI innovation tools in healthcare. Learn more: https://lnkd.in/eARkUWiK
📣 Exciting news from Omada Health! New claims data analysis demonstrated lower healthcare utilization and spending, compared to traditional in-person PT, for members in the Omada for Joint & Muscle Health program. 🏥💡 Published in PTJ: Physical Therapy & Rehabilitation Journal and using claims data sourced from HealthVerity, this study revealed a reduction in overall healthcare utilization and MSK-related costs, leading to over $1,000 in gross median savings per member at both six and 12 months. As MSK-related treatments account for nearly 15% of employer medical costs, Omada's virtual MSK program presents a compelling, cost-effective option for physical therapy. Learn more in our press release: https://lnkd.in/eFcrs-R6
🌟 This month, we're celebrating MENA Heritage Month at Omada, recognizing the rich tapestry of Middle Eastern and North African cultures, traditions, and contributions to our society. The MENA region represents a vibrant mosaic of identities - from diverse languages like Arabic, Persian, Hebrew, Turkish, and Amazigh, to distinctive art forms, music, and culinary traditions that have enriched global culture. Our MENA ERG is hosting a special virtual performance and conversation, "Finding Home Through Music & Story," exploring what it means to find "home" away from home through live music and storytelling. Through these shared experiences, we'll discover how creativity can become a bridge across distances and a vessel for identity and connection. We're honored to create spaces where all employees can share their heritage, learn from one another, and build a more inclusive workplace together. 🌍 #MENAHeritageMonth #BelongingAtOmada
🔥 Take: The magic of AI isn’t in the algorithm. Proof Points looks a little different this month! In our first commercial guest op-ed, Omada’s Regional VP of Health Plan Sales, Michael Alexander, lends his creative writing prowess to paint a vivid picture of healthcare’s future, and gives voice to what many in the industry are thinking in terms of AI, interoperability, patient outcomes and everything in between. Enjoy this enlightening read, which includes historic parallels and wisdom from a little blue fish. 🐟
🌟 Proud to spotlight Thomas Cokely Cloyd, co-leader of our Capability Employee Resource Group (ERG) and a passionate advocate for disability inclusion, recently featured in UMN Carlson School of Management's alumni spotlight! Under Thomas's co-leadership, our Capability ERG has implemented several impactful initiatives supporting Omadans and members across the disability spectrum, including: 💫 Company-wide disability awareness training 💫 Font extension approval for enhanced readability 💫 Neuroinclusive business document writing best practices 💫 Improved accessibility in health coach training videos 💫 Enhanced disability inclusivity in company planning guides Alongside his co-leads and colleagues within the Capability ERG, Thomas helps build a community focused on understanding, empowerment, and support for those living with disabilities, their allies, and caregivers. Read more about Thomas's journey and impact: https://lnkd.in/eXpchVUe
Excited to share new insights from members in our Enhanced GLP-1 Care Track! The latest analysis reveals the importance of medication persistence. We found that, on average, members in the Enhanced GLP-1 Care Track not only actively engaged with the program, they also received support in staying on their GLP-1 medications long enough to see clinically meaningful results. Why does this matter? 🌟Medication and lifestyle support don't exist in silos - they work together. 🌟 Investing in these medications is more likely to be worthwhile for those who persist on a GLP-1 medication long enough to experience the medication’s intended clinical results, while also learning the skills needed to maintain these benefits. Learn more in the white paper: https://lnkd.in/eWFPyUCk
Wei-Li Shao shares his POV on what's to come in the GLP-1 space - check it out in BenefitsPRO: https://lnkd.in/e_XYkXam
